Renal-artery stenosis

New England Journal of Medicine

Volumn 344, Issue 6, 2001, Pages 431-442

  Safian, Robert D ^a   Textor, Stephen C ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALGORITHM; CHRONIC KIDNEY FAILURE; CLINICAL EXAMINATION; CORRELATION FUNCTION; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW;

BALLOON DILATATION; DISEASE PROGRESSION; FIBROMUSCULAR DYSPLASIA; HUMANS; HYPERTENSION, RENOVASCULAR; ISCHEMIA; KIDNEY; KIDNEY DISEASES; RENAL ARTERY OBSTRUCTION;

EID: 0035825718     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200102083440607     Document Type: Review

References (89)

1. Etiologic factors in renovascular fibromuscular dysplasia: A case-controlled study
2. Prevalence of renal artery stenosis in diabetes mellitus - An autopsy study
3. Renovascular hypertension: Anatomic and renal function changes during therapy
4. Natural history of atherosclerotic renal artery stenosis associated with aortic disease
5. Progression of renal artery stenosis in patients undergoing cardiac catheterization
6. Prospective study of atherosclerotic disease progression in the renal artery
7. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis
8. Natural history of atherosclerotic renal artery stenosis: A prospective study with duplex ultrasonography
9. An epidemiological approach to describing risk associated with blood pressure levels: Final report of the Working Group on Risk and High Blood Pressure
10. Interactions of transforming growth factorbeta and angiotensin II in renal fibrosis
11. Clinical characteristics of renovascular hypertension
12. The significance of captopril renography in renovascular hypertension
13. Captopril renography in the diagnosis of renal artery stenosis and the prediction of improvement with revascularization: The Yale Vascular Center experience
14. Renal duplex sonography: Evaluation of clinical utility
15. Magnetic resonance angiography of renal artery stenosis
16. Helical CT angiography compared with arteriography in the detection of renal artery stenosis
17. Renal insufficiency: Gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures
18. ACE inhibitors in renovascular hypertension
19. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat
20. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney
21. Evolution of renal insufficiency in ischemic nephropathy
22. Renal atrophy and arterial stenosis: A prospective study with duplex ultrasound
23. Changing patterns in surgery for chronic renal artery occlusive diseases
24. Contemporary surgical management of renovascular disease
25. Renal revascularization to preserve and restore renal function
26. The durability of different reconstructive techniques for atherosclerotic renal artery disease
27. Trends in surgical revascularization for renal artery disease: Ten years' experience
28. Safety and efficacy of transaortic renal endarterectomy as an adjunct to aortic surgery
29. Simultaneous surgical management of aortic and renovascular disease
30. Simultaneous aortic reconstruction and renal revascularization: Risk factors and late results in eighty-nine patients
31. Complications of abdominal aortic reconstruction: An analysis of perioperative risk factors in 557 patients
32. Renovascular reconstruction: Factors affecting long-term prognosis in 919 patients followed up to 31 years
33. Ischemic nephropathy and concomitant aortic disease: A ten-year experience
34. Aortic and renal vascular disease: Factors affecting the value of combined procedures
35. Long-term effectiveness of extraanatomic renal artery revascularization
36. Long-term survival after surgical revascularization for atherosclerotic renal artery disease
37. Percutaneous angioplasty of the renal arteries
38. The indications and results of percutaneous transluminal angioplasty and stenting in renal artery stenosis
39. Percutaneous transluminal angioplasty: The treatment of choice for renovascular hypertension due to fibromuscular dysplasia
40. The current role of renal angioplasty in the treatment of renovascular hypertension
41. Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: Midterm technical and clinical results
42. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty
43. Renal artery angioplasty: Technical results and clinical outcome in 320 patients
44. Percutaneous transluminal renal angioplasty in management of atherosclerotic renovascular hypertension: Results in 100 patients
45. Percutaneous transluminal renal angioplasty: Initial and long-term results
46. Stenting of a renal artery stenosis achieves better relief of the obstructive lesion than balloon angioplasty
47. Effect of primary balloon expandable renal artery stenrs on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis
48. Renal artery stent placement: Utility in lesions difficult to treat with balloon angioplasty
49. Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis
50. Renal artery stent placement for the management of ischemic nephropathy
51. Primary stenting of atherosclerotic renal artery ostial stenosis
52. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis
53. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: A prospective randomized study
54. Clinical outcome and health care costs in renal revascularization - Percutaneous transluminal renal angioplasty versus reconstructive surgery
55. Comparison of clinical outcome and cost of renal artery angioplasty (PTRA), stenting (RAS), and bypass grafts (RABG)
56. Surgery and percutaneous angioplasty in the management of renovascular hypertension
57. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: An overview of published series
58. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial
59. Randomized comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis
60. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis
61. Pathophysiology of renal failure in renovascular disease
62. Renal nitric oxide and angiotensin II interaction in renovascular hypertension
63. The pathology of chronic renal ischemia
64. Ischemic renal disease: An overlooked clinical entity?
65. Renal revascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: A distinct subgroup of patients with arteriosclerotic renal artery occlusive disease
66. Atherosclerotic renovascular disease
67. Predictors of survival in patients undergoing dialysis
68. Revascularization in atherosclerotic renal artery disease
69. Medical therapy of renovascular hypertension: Efficacy and safety of captopril in 269 patients
70. Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis
71. Reversible acute renal failure as an atypical presentation of ischemic nephropathy
72. Reversal of acute renal failure following percutaneous transluminal recanalization of an atherosclerotic renal artery occlusion
73. Atherosclerotic renovascular disease causing renal impairment - A case for treatment
74. Prevalence of ischemic nephropathy in patients with renal insufficiency
75. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: A 20-year clinical experience
76. Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease
77. Revascularization to preserve renal function in patients with atherosclerotic renovascular disease
78. Report of the Radionuclides in Nephrourology Committee on renal clearance
79. Progressive renal dysfunction despite successful renal artery angioplasty in a single kidney
80. Renal revascularization in the azotemic hypertensive patient resistant to therapy
81. Survival in renal vascular disease
82. Retrieval of renal function by revascularization: Study of preoperative outcome predictors
83. Unilateral renal artery revascularization can salvage renal function and terminate dialysis in selected patients with uremia
84. Successful revascularization of an occluded renal artery after prolonged anuria
85. Simultaneous reconstruction of infrarenal abdominal aorta and renal arteries
86. Surgery: Indications and variables that affect procedural outcome, as well as morbidity and mortality
87. Management of renovascular hypertension in the elderly population
88. Renal artery stent placement in renal artery stenosis: Technical and early clinical results
89. Effect of renal-artery stenting on progression of renovascular renal failure